Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 06, 2020

SELL
$6.53 - $8.6 $163,250 - $215,000
-25,000 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$4.11 - $6.78 $20,550 - $33,900
-5,000 Reduced 16.67%
25,000 $164,000
Q1 2020

May 15, 2020

SELL
$3.15 - $7.39 $116,550 - $273,430
-37,000 Reduced 55.22%
30,000 $153,000
Q4 2019

Feb 12, 2020

SELL
$5.01 - $8.16 $78,010 - $127,059
-15,571 Reduced 18.86%
67,000 $514,000
Q2 2019

Aug 14, 2019

BUY
$3.43 - $5.6 $283,218 - $462,397
82,571 New
82,571 $462,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.